Click to enlarge

Glucoadjust

Glucoadjust belongs to SGLT2 Inhibitors class.
It is a combination of two oral antidiabetic agents Empagliflozin and Metformin . It is used in adults with type II and with those who have known cardiovascular diseases control when diet, physical exercise and weight loss are not enough.

DOWNLOAD PAMPHLET
Description
  • Tablet
Generic Name & Amount Pack Sizes Indications
Each tablet contains:
Empagliflozin 5 Mg + Metformin 500 Mg
Empagliflozin 12.5 Mg + Metformin 500 Mg 		Tablets:
3 x 10 Tabs
3 x 10 Tabs
 Therapeutic indications
indicated for the treatment of adults with type 2 diabetes
mellitus as an adjunct to diet and exercise:
• In patients insufficiently controlled on their maximally tolerated
dose of metformin alone.
• In combination with other medicinal products for the treatment
of diabetes, in patients insufficiently controlled with metformin
and these medicinal products.
• In patients already being treated with the combination
of empagliflozin and metformin as separate tablets.
  • Tablet

GENERIC NAME & AMOUNT

Each tablet contains:
Empagliflozin 5 Mg + Metformin 500 Mg
Empagliflozin 12.5 Mg + Metformin 500 Mg

PACK SIZES

Tablets:
3 x 10 Tabs
3 x 10 Tabs

INDICATIONS

Therapeutic indications
indicated for the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise:

  • In patients insufficiently controlled on their maximally tolerated dose of metformin alone.
  • In combination with other medicinal products for the treatment of diabetes, in patients insufficiently controlled with metformin and these medicinal products.
  • In patients already being treated with the combination of empagliflozin and metformin as separate tablets.